MedPath

Clinical significance of [-2]proPSA during active surveillance for localized prostate cancer

Phase 2
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000009876
Lead Sponsor
Department of Urology, Kagawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
1100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Men who can not or do not want to be radiated or operated. 2) A former therapy for prostate cancer. 3) For patients with a life expectancy of <10yr, watchful waiting is preferred above Active Surveillance.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reclassification at repeat biopsy
Secondary Outcome Measures
NameTimeMethod
1)reclassification at secondary radical prostatectomy specimen 2)active surveillance remaining rate 3)clinical progression 4)distant metastasis 5)overall survival
© Copyright 2025. All Rights Reserved by MedPath